logo
Select company
Select metric
$ 3.1MGross Profit
VS
Market
19
Sector
45
Industry
64
History
5
$ 1.01Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information

Ticker

NBY

Company Name

NOVABAY PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NOVABAY PHARMACEUTICALS INC - Gross Profit Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NBY - GP Historical data
DateGross Profit
6/30/2025$ 3.1M
3/31/2025$ 4.69M
12/31/2024$ 6.48M
9/30/2024$ 6.79M
6/30/2024$ 7.04M
3/31/2024$ 7.75M
12/31/2023$ 7.89M
9/30/2023$ 7.83M
6/30/2023$ 8.37M
3/31/2023$ 7.62M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) GP stands at $ 6M.
  • Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average GP has been $ 6.42M.
  • The median GP for NOVABAY PHARMACEUTICALS INC during this period was $ 6.24M
  • NOVABAY PHARMACEUTICALS INC reached its highest GP over the past 5 years at $ 8.37M.
  • The lowest GP recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe $ 3.1M

NOVABAY PHARMACEUTICALS INC's GP vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GP Benchmarks
CompanyGP
INM : INMED PHARMACEUTICALS INC $ 1.71MXBIO : XENETIC BIOSCIENCES INC $ 2.45MCNSP : CNS PHARMACEUTICALS INC $ 0ENVB : ENVERIC BIOSCIENCES INC $ 0CPHI : CHINA PHARMA HOLDINGS INC $ -903.31KGRI : GRI BIO INC $ 0AZTR : AZITRA INC $ 0ONCO : ONCONETIX INC $ 881.72KSPRB : SPRUCE BIOSCIENCES INC $ 1.3MREVB : REVELATION BIOSCIENCES INC $ 0

Definition of Gross Profit

[Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].

NBY - Gross Profit, Last 5 years

$ 3.1M

Minimum

Jun 30, 2025

$ 8.37M

Maximum

Jun 30, 2023

$ 6.42M

Average

$ 6.24M

Median

GP Benchmark Analysis

The chart above depicts the distribution of GP for companies in the Total Stock Market. The average GP of the companies is $ 245.61M with a standard deviation of $ 328.72M.
The following table provides additional summary stats:
GP in the Market:
filtered constituents3.34K
min$ -790.38M
max$ 1.32B
average$ 245.61M
median$ 93.41M
std$ 328.72M